** Shares of Pacific Edge PEB.NZ rise 138% to NZ$0.15, their highest level since November 13, 2024
** Cancer diagnostics company announces that the American Urological Association has included its Cxbladder Triage as the standard of care for microhematuria
** Cxbladder Triage is a urine test designed to rule out cancer in patients with microhematuria (small amounts of blood in the urine that are not visible to the naked eye)
** Company expects a rise in demand for the tests as more clinicians incorporate the tests globally for the evaluation and management of patients
** Two million shares change hands, 2.6 times the 30-day average of 791,598 shares
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.